Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adaptimmune Therapeutics Plc (ADAP) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adaptimmune Therapeutics Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1621227.
Total stock buying since 2016: $526,300,873.
Total stock sales since 2016: $47,729,317.
Total stock option exercises since 2016: $533,798.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 84,017,188 | $7,230,032 | 0 | $0 |
| 2024 | 0 | $0 | 190,330 | $147,193 | 0 | $0 |
| 2023 | 0 | $0 | 159,882 | $234,323 | 0 | $0 |
| 2022 | 39,000 | $11,310 | 96,884 | $286,541 | 0 | $0 |
| 2021 | 0 | $0 | 48,361 | $254,039 | 1,785,000 | $280,245 |
| 2020 | 45,276,900 | $30,253,266 | 1,128,854 | $8,360,647 | 0 | $0 |
| 2019 | 0 | $0 | 20,940 | $75,882 | 1,773,100 | $253,553 |
| 2018 | 204,444,000 | $360,155,065 | 3,146,134 | $31,140,660 | 0 | $0 |
| 2017 | 131,080,952 | $100,089,998 | 0 | $0 | 0 | $0 |
| 2016 | 3,484,800 | $35,791,234 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 96,000 | $960 | 0 | $0 |
| 2025-08 | 0 | $0 | 19,707,000 | $231,241 | 0 | $0 |
| 2025-07 | 0 | $0 | 64,052,538 | $6,903,919 | 0 | $0 |
| 2025-01 | 0 | $0 | 161,650 | $93,912 | 0 | $0 |
| 2024-06 | 0 | $0 | 24,531 | $22,813 | 0 | $0 |
| 2024-01 | 0 | $0 | 165,799 | $124,380 | 0 | $0 |
| 2023-09 | 0 | $0 | 2,403 | $1,874 | 0 | $0 |
| 2023-08 | 0 | $0 | 3,096 | $2,804 | 0 | $0 |
| 2023-07 | 0 | $0 | 47,702 | $43,456 | 0 | $0 |
| 2023-06 | 0 | $0 | 2,333 | $2,146 | 0 | $0 |
| 2023-01 | 0 | $0 | 104,348 | $184,043 | 0 | $0 |
| 2022-09 | 0 | $0 | 2,536 | $4,993 | 0 | $0 |
| 2022-08 | 0 | $0 | 24,023 | $42,615 | 0 | $0 |
| 2022-07 | 0 | $0 | 1,973 | $3,310 | 0 | $0 |
| 2022-06 | 0 | $0 | 2,562 | $4,176 | 0 | $0 |
| 2022-05 | 39,000 | $11,310 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 65,790 | $231,447 | 0 | $0 |
| 2021-09 | 0 | $0 | 2,782 | $14,452 | 0 | $0 |
| 2021-08 | 0 | $0 | 2,939 | $10,536 | 0 | $0 |
| 2021-07 | 0 | $0 | 6,282 | $26,792 | 0 | $0 |
| 2021-06 | 0 | $0 | 2,794 | $12,209 | 0 | $0 |
| 2021-03 | 0 | $0 | 0 | $0 | 1,785,000 | $280,245 |
| 2021-01 | 0 | $0 | 33,564 | $190,050 | 0 | $0 |
| 2020-12 | 231,000 | $160,425 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | Wood Gavin (Chief Financial Officer) | Sale | 96,000 | .01 | 960 |
| 2025-08-28 | Bertrand William C Jr (Chief Operating Officer) | Sale | 207,000 | .01 | 2,070 |
| 2025-08-18 | Behbahani Ali | Sale | 14,671,794 | .01 | 176,061 |
| 2025-08-15 | Behbahani Ali | Sale | 4,828,206 | .01 | 53,110 |
| 2025-07-30 | Ecor1 Capital, Llc | Sale | 27,433,338 | .10 | 2,798,200 |
| 2025-07-29 | Ecor1 Capital, Llc | Sale | 2,687,460 | .10 | 271,433 |
| 2025-07-28 | Ecor1 Capital, Llc | Sale | 33,931,740 | .11 | 3,834,286 |
| 2025-01-17 | Norry Elliot (Chief Medical Officer) | Sale | 5,584 | .58 | 3,244 |
| 2025-01-17 | Lunger John (Chief Patient Supply Officer) | Sale | 5,584 | .58 | 3,244 |
| 2025-01-17 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 30,601 | .58 | 17,779 |
| 2025-01-17 | Bertrand William C Jr (Chief Operating Officer) | Sale | 5,584 | .58 | 3,244 |
| 2025-01-15 | Piccina Cintia (Chief Commercial Officer) | Sale | 12,991 | .57 | 7,469 |
| 2025-01-15 | Norry Elliot (Chief Medical Officer) | Sale | 9,803 | .57 | 5,636 |
| 2025-01-15 | Lunger John (Chief Patient Supply Officer) | Sale | 9,803 | .57 | 5,636 |
| 2025-01-15 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 29,096 | .57 | 16,730 |
| 2025-01-13 | Norry Elliot (Chief Medical Officer) | Sale | 12,392 | .59 | 7,286 |
| 2025-01-13 | Lunger John (Chief Patient Supply Officer) | Sale | 9,739 | .59 | 5,726 |
| 2025-01-13 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 30,473 | .59 | 17,918 |
| 2024-06-18 | Piccina Cintia (Chief Commercial Officer) | Sale | 24,531 | .93 | 22,813 |
| 2024-01-17 | Norry Elliot (Chief Medical Officer) | Sale | 18,276 | .67 | 12,299 |
| 2024-01-17 | Lunger John (Chief Patient Supply Officer) | Sale | 18,114 | .67 | 12,190 |
| 2024-01-17 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 30,080 | .67 | 20,243 |
| 2024-01-17 | Bertrand William C Jr (Chief Operating Officer) | Sale | 18,908 | .67 | 12,725 |
| 2024-01-16 | Norry Elliot (Chief Medical Officer) | Sale | 2,287 | .79 | 1,806 |
| 2024-01-16 | Lunger John (Chief Patient Supply Officer) | Sale | 4,681 | .79 | 3,697 |
| 2024-01-16 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 9,304 | .79 | 7,350 |
| 2024-01-16 | Bertrand William C Jr (Chief Operating Officer) | Sale | 4,681 | .79 | 3,697 |
| 2024-01-12 | Norry Elliot (Chief Medical Officer) | Sale | 7,799 | .85 | 6,660 |
| 2024-01-12 | Lunger John (Chief Patient Supply Officer) | Sale | 5,220 | .85 | 4,457 |
| 2024-01-12 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 17,257 | .85 | 14,737 |
| 2024-01-12 | Bertrand William C Jr (Chief Operating Officer) | Sale | 5,220 | .85 | 4,457 |
| 2024-01-11 | Norry Elliot (Chief Medical Officer) | Sale | 4,009 | .84 | 3,355 |
| 2024-01-11 | Lunger John (Chief Patient Supply Officer) | Sale | 4,009 | .84 | 3,355 |
| 2024-01-11 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 11,945 | .84 | 9,997 |
| 2024-01-11 | Bertrand William C Jr (Chief Operating Officer) | Sale | 4,009 | .84 | 3,355 |
| 2023-09-01 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,403 | .78 | 1,874 |
| 2023-08-01 | Lunger John (Chief Patient Supply Officer) | Sale | 3,096 | .91 | 2,804 |
| 2023-07-10 | Menzel Garry E | Sale | 47,702 | .91 | 43,456 |
| 2023-06-27 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,333 | .92 | 2,146 |
| 2023-01-31 | Piccina Cintia (Chief Commercial Officer) | Sale | 11,890 | 1.87 | 22,234 |
| 2023-01-17 | Norry Elliot (Chief Medical Officer) | Sale | 2,159 | 1.86 | 4,011 |
| 2023-01-17 | Lunger John (Chief Patient Supply Officer) | Sale | 4,440 | 1.86 | 8,249 |
| 2023-01-17 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 10,057 | 1.86 | 18,685 |
| 2023-01-17 | Bertrand William C Jr (Chief Operating Officer) | Sale | 4,440 | 1.86 | 8,249 |
| 2023-01-12 | Norry Elliot (Chief Medical Officer) | Sale | 7,449 | 1.71 | 12,707 |
| 2023-01-12 | Lunger John (Chief Patient Supply Officer) | Sale | 4,973 | 1.71 | 8,483 |
| 2023-01-12 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 18,763 | 1.71 | 32,009 |
| 2023-01-12 | Bertrand William C Jr (Chief Operating Officer) | Sale | 4,973 | 1.71 | 8,483 |
| 2023-01-11 | Norry Elliot (Chief Medical Officer) | Sale | 3,843 | 1.75 | 6,713 |
| 2023-01-11 | Lunger John (Chief Patient Supply Officer) | Sale | 3,843 | 1.75 | 6,713 |
| 2023-01-11 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 13,042 | 1.75 | 22,784 |
| 2023-01-11 | Bertrand William C Jr (Chief Operating Officer) | Sale | 3,843 | 1.75 | 6,713 |
| 2023-01-04 | Norry Elliot (Chief Medical Officer) | Sale | 876 | 1.69 | 1,483 |
| 2023-01-04 | Lunger John (Chief Patient Supply Officer) | Sale | 1,100 | 1.69 | 1,863 |
| 2023-01-04 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 5,073 | 1.69 | 8,593 |
| 2023-01-04 | Bertrand William C Jr (Chief Operating Officer) | Sale | 3,584 | 1.69 | 6,071 |
| 2022-09-01 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,536 | 1.97 | 4,993 |
| 2022-08-01 | Piccina Cintia (Chief Commercial Officer) | Sale | 21,040 | 1.77 | 37,324 |
| 2022-08-01 | Lunger John (Chief Patient Supply Officer) | Sale | 2,983 | 1.77 | 5,291 |
| 2022-07-05 | Lunger John (Chief Patient Supply Officer) | Sale | 1,973 | 1.68 | 3,310 |
| 2022-06-27 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,562 | 1.63 | 4,176 |
| 2022-05-20 | Wood Gavin (Chief Financial Officer) | Buy | 39,000 | .29 | 11,310 |
| 2022-01-18 | Norry Elliot (Chief Medical Officer) | Sale | 2,121 | 3.19 | 6,770 |
| 2022-01-18 | Lunger John (Chief Patient Supply Officer) | Sale | 4,368 | 3.19 | 13,942 |
| 2022-01-18 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 11,096 | 3.19 | 35,418 |
| 2022-01-18 | Bertrand William C Jr (Chief Operating Officer) | Sale | 4,368 | 3.19 | 13,942 |
| 2022-01-12 | Norry Elliot (Chief Medical Officer) | Sale | 854 | 3.54 | 3,026 |
| 2022-01-12 | Lunger John (Chief Patient Supply Officer) | Sale | 1,076 | 3.54 | 3,813 |
| 2022-01-12 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 3,046 | 3.54 | 10,795 |
| 2022-01-12 | Bertrand William C Jr (Chief Operating Officer) | Sale | 2,248 | 3.54 | 7,966 |
| 2022-01-11 | Norry Elliot (Chief Medical Officer) | Sale | 3,770 | 3.56 | 13,409 |
| 2022-01-11 | Lunger John (Chief Patient Supply Officer) | Sale | 3,770 | 3.56 | 13,409 |
| 2022-01-11 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 14,362 | 3.56 | 51,085 |
| 2022-01-11 | Bertrand William C Jr (Chief Operating Officer) | Sale | 3,770 | 3.56 | 13,409 |
| 2022-01-04 | Norry Elliot (Chief Medical Officer) | Sale | 849 | 4.06 | 3,450 |
| 2022-01-04 | Lunger John (Chief Patient Supply Officer) | Sale | 1,070 | 4.06 | 4,348 |
| 2022-01-04 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 5,532 | 4.06 | 22,482 |
| 2022-01-04 | Bertrand William C Jr (Chief Operating Officer) | Sale | 3,490 | 4.06 | 14,183 |
| 2021-09-01 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,782 | 5.20 | 14,452 |
| 2021-08-02 | Lunger John (Chief Patient Supply Officer) | Sale | 2,939 | 3.58 | 10,536 |
| 2021-07-02 | Lunger John (Chief Patient Supply Officer) | Sale | 1,907 | 4.26 | 8,133 |
| 2021-07-02 | Bertrand William C Jr (Chief Operating Officer) | Sale | 4,375 | 4.26 | 18,659 |
| 2021-06-28 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,794 | 4.37 | 12,209 |
| 2021-03-03 | Tayton-martin Helen Katrina (Chief Business Officer) | Option Ex | 1,785,000 | .16 | 280,245 |
| 2021-01-19 | Norry Elliot (Chief Medical Officer) | Sale | 2,111 | 5.67 | 11,969 |
| 2021-01-19 | Lunger John (Chief Patient Supply Officer) | Sale | 4,358 | 5.67 | 24,709 |
| 2021-01-19 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 9,879 | 5.67 | 56,013 |
| 2021-01-12 | Norry Elliot (Chief Medical Officer) | Sale | 841 | 6.15 | 5,173 |
| 2021-01-12 | Lunger John (Chief Patient Supply Officer) | Sale | 1,058 | 6.15 | 6,508 |
| 2021-01-12 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,707 | 6.15 | 16,653 |
| 2021-01-12 | Bertrand William C Jr (Chief Operating Officer) | Sale | 2,234 | 6.15 | 13,743 |
| 2021-01-04 | Norry Elliot (Chief Medical Officer) | Sale | 845 | 5.33 | 4,502 |
| 2021-01-04 | Lunger John (Chief Patient Supply Officer) | Sale | 1,065 | 5.33 | 5,674 |
| 2021-01-04 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 4,967 | 5.33 | 26,464 |
| 2021-01-04 | Bertrand William C Jr (Chief Operating Officer) | Sale | 3,499 | 5.33 | 18,642 |
| 2020-12-14 | Wood Gavin (Chief Financial Officer) | Buy | 24,000 | .69 | 16,560 |
| 2020-12-14 | Bertrand William C Jr (Chief Operating Officer) | Buy | 207,000 | .69 | 143,865 |
| 2020-09-01 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,776 | 8.52 | 23,637 |
| 2020-08-03 | Lunger John (Chief Patient Supply Officer) | Sale | 4,823 | 9.25 | 44,612 |
| 2020-08-03 | Tayton-martin Helen Katrina (Chief Business Officer) | Sale | 200,000 | 8.74 | 1,748,200 |
| 2020-08-03 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 2,788 | 9.25 | 25,789 |
| 2020-06-29 | Wood Gavin (Chief Financial Officer) | Buy | 33,000 | 1.62 | 53,460 |
| 2020-06-09 | Alleva Lawrence M (Director) | Buy | 12,900 | 1.89 | 24,381 |
| 2020-05-29 | Noble James (Director) | Sale | 500,000 | 9.33 | 4,666,000 |
| 2020-01-24 | Behbahani Ali (Director) | Buy | 7,500,000 | .67 | 5,002,500 |
| 2020-01-24 | Florence Anthony A. Jr. (10% Owner) | Buy | 7,500,000 | .67 | 5,002,500 |
| 2020-01-24 | Sonsini Peter W. (10% Owner) | Buy | 7,500,000 | .67 | 5,002,500 |
| 2020-01-24 | Baskett Forest (10% Owner) | Buy | 7,500,000 | .67 | 5,002,500 |
| 2020-01-24 | Sandell Scott D (10% Owner) | Buy | 7,500,000 | .67 | 5,002,500 |
| 2020-01-24 | Mott David M (Director) | Buy | 7,500,000 | .67 | 5,002,500 |
| 2020-01-14 | Norry Elliot (Chief Medical Officer) | Sale | 911 | 5.13 | 4,677 |
| 2020-01-14 | Lunger John (Chief Patient Supply Officer) | Sale | 1,144 | 5.13 | 5,874 |
| 2020-01-14 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 3,236 | 5.13 | 16,616 |
| 2020-01-14 | Bertrand William C Jr (Chief Operating Officer) | Sale | 2,397 | 5.13 | 12,308 |
| 2020-01-13 | Tayton-martin Helen Katrina (Chief Business Officer) | Sale | 100,000 | 4.50 | 450,000 |
| 2020-01-13 | Noble James (Director) | Sale | 300,000 | 4.50 | 1,350,000 |
| 2020-01-06 | Lunger John (Chief Patient Supply Officer) | Sale | 1,148 | 1.20 | 1,377 |
| 2020-01-06 | Rawcliffe Adrian (Chief Executive Officer) | Sale | 5,900 | 1.20 | 7,080 |
| 2020-01-06 | Bertrand William C Jr (Chief Operating Officer) | Sale | 3,731 | 1.20 | 4,477 |
| 2019-08-06 | Amado Rafael (President, R&D) | Sale | 11,043 | 2.06 | 22,748 |
| 2019-05-16 | Noble James (Chief Executive Officer) | Option Ex | 1,773,100 | .14 | 253,553 |
| 2019-01-14 | Amado Rafael (President, R & D) | Sale | 3,028 | 5.37 | 16,257 |
| 2019-01-14 | Binder-scholl Gwendolyn Knowlton (Chief Technology Officer) | Sale | 1,514 | 5.37 | 8,128 |
| 2019-01-14 | Rawcliffe Adrian (Chief Financial Officer) | Sale | 3,084 | 5.37 | 16,557 |
| 2019-01-14 | Bertrand William C Jr (Chief Operating Officer) | Sale | 2,271 | 5.37 | 12,192 |
| 2018-12-17 | Alleva Lawrence M (Director) | Buy | 47,280 | .84 | 39,715 |
| 2018-10-01 | Binder-scholl Gwendolyn Knowlton (Chief Technology Officer) | Sale | 25,000 | 13.79 | 344,750 |
| 2018-09-07 | Behbahani Ali (Director) | Buy | 12,000,000 | 1.67 | 20,004,000 |
| 2018-09-07 | Florence Anthony A. Jr. (10% Owner) | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-09-07 | Sonsini Peter W. (10% Owner) | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-09-07 | Nea 14 Gp, Ltd (10% Owner) | Buy | 3,000,000 | 1.67 | 5,001,000 |
| 2018-09-07 | Viswanathan Ravi (10% Owner) | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-09-07 | Baskett Forest (10% Owner) | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-09-07 | Sandell Scott D (10% Owner) | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-09-07 | Kerins Patrick J (10% Owner) | Buy | 3,000,000 | 1.67 | 5,001,000 |
| 2018-09-07 | Mott David M (Director) | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-09-07 | Barrett M James (10% Owner) | Buy | 3,000,000 | 1.67 | 5,001,000 |
| 2018-09-07 | Barris Peter J (10% Owner) | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-08-29 | Binder-scholl Gwendolyn Knowlton (Chief Technology Officer) | Sale | 25,000 | 10.25 | 256,250 |
| 2018-06-06 | Orbimed Capital Gp V Llc | Sale | 1,600 | 13.49 | 21,584 |
| 2018-06-06 | Thompson Peter A. | Sale | 1,600 | 13.49 | 21,584 |
| 2018-06-04 | Orbimed Capital Gp V Llc | Sale | 17,100 | 13.57 | 232,047 |
| 2018-06-04 | Thompson Peter A. | Sale | 17,100 | 13.57 | 232,047 |
| 2018-06-01 | Orbimed Capital Gp V Llc | Sale | 50,000 | 13.49 | 674,500 |
| 2018-06-01 | Thompson Peter A. | Sale | 50,000 | 13.49 | 674,500 |
| 2018-05-30 | Orbimed Capital Gp V Llc | Sale | 121,000 | 13.52 | 1,635,920 |
| 2018-05-30 | Thompson Peter A. | Sale | 121,000 | 13.52 | 1,635,920 |
| 2018-05-14 | Orbimed Capital Gp V Llc | Sale | 10,300 | 13.50 | 139,050 |
| 2018-05-14 | Thompson Peter A. | Sale | 10,300 | 13.50 | 139,050 |
| 2018-03-29 | Orbimed Capital Gp V Llc | Sale | 31,983 | 11.53 | 368,763 |
| 2018-03-29 | Thompson Peter A. | Sale | 31,983 | 11.53 | 368,763 |
| 2018-03-27 | Orbimed Capital Gp V Llc | Sale | 1,016,084 | 11.50 | 11,684,966 |
| 2018-03-27 | Florence Anthony A. Jr. (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Sonsini Peter W. (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Nea 14 Gp, Ltd (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Viswanathan Ravi (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Thompson Peter A. | Sale | 1,016,084 | 11.50 | 11,684,966 |
| 2018-03-27 | Baskett Forest (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Sandell Scott D (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Kerins Patrick J (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Mott David M (Director) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Barrett M James (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-27 | Barris Peter J (10% Owner) | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-26 | Florence Anthony A. Jr. (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Sonsini Peter W. (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Nea 14 Gp, Ltd (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Viswanathan Ravi (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Baskett Forest (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Sandell Scott D (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Kerins Patrick J (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Mott David M (Director) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Barrett M James (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-26 | Barris Peter J (10% Owner) | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-23 | Florence Anthony A. Jr. (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Sonsini Peter W. (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Nea 14 Gp, Ltd (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Viswanathan Ravi (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Baskett Forest (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Sandell Scott D (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Kerins Patrick J (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Mott David M (Director) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Barrett M James (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-23 | Barris Peter J (10% Owner) | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-22 | Florence Anthony A. Jr. (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Sonsini Peter W. (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Nea 14 Gp, Ltd (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Viswanathan Ravi (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Baskett Forest (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Sandell Scott D (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Kerins Patrick J (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Mott David M (Director) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Barrett M James (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-22 | Barris Peter J (10% Owner) | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-21 | Florence Anthony A. Jr. (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Sonsini Peter W. (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Nea 14 Gp, Ltd (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Viswanathan Ravi (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Baskett Forest (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Sandell Scott D (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Kerins Patrick J (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Mott David M (Director) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Barrett M James (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-21 | Barris Peter J (10% Owner) | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-20 | Rawcliffe Adrian (Chief Financial Officer) | Sale | 600,000 | 1.71 | 1,026,000 |
| 2017-03-27 | Florence Anthony A. Jr. (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Sonsini Peter W. (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Nea 14 Gp, Ltd (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Viswanathan Ravi (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Thompson Peter A. | Buy | 1,190,476 | 4.20 | 4,999,999 |
| 2017-03-27 | Baskett Forest (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Sandell Scott D (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Kerins Patrick J (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Mott David M (Director) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Barrett M James (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2017-03-27 | Isaly Samuel D | Buy | 1,190,476 | 4.20 | 4,999,999 |
| 2017-03-27 | Barris Peter J (10% Owner) | Buy | 12,870,000 | .70 | 9,009,000 |
| 2016-05-24 | Thompson Peter A. | Buy | 518,400 | 10.48 | 5,432,832 |
| 2016-05-24 | Isaly Samuel D | Buy | 518,400 | 10.48 | 5,432,832 |
| 2016-05-23 | Thompson Peter A. | Buy | 1,191,600 | 10.40 | 12,392,640 |
| 2016-05-23 | Isaly Samuel D | Buy | 1,191,600 | 10.40 | 12,392,640 |
| 2016-05-20 | Thompson Peter A. | Buy | 2,400 | 10.04 | 24,095 |
| 2016-05-20 | Isaly Samuel D | Buy | 2,400 | 10.04 | 24,095 |
| 2016-05-19 | Sigal Charles Elliott (Director) | Buy | 15,000 | 1.56 | 23,400 |
| 2016-05-18 | Sigal Charles Elliott (Director) | Buy | 15,000 | 1.55 | 23,250 |
| 2016-05-17 | Sigal Charles Elliott (Director) | Buy | 15,000 | 1.53 | 22,950 |
| 2016-05-16 | Sigal Charles Elliott (Director) | Buy | 15,000 | 1.50 | 22,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of ADAP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adaptimmune Therapeutics Plc (symbol ADAP, CIK number 1621227) see the Securities and Exchange Commission (SEC) website.